Hepatic steatosis is defined as pathologically elevated liver fat content and has many
underlying causes. Nonalcoholic fatty liver disease (NAFLD) is the most common chronic …

Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …

Hepatic steatosis is a frequently encountered imaging finding that may indicate chronic liver
disease, the most common of which is non-alcoholic fatty liver disease. Non-alcoholic fatty …

Purpose To determine the linearity, bias, and precision of hepatic proton density fat fraction
(PDFF) measurements by using magnetic resonance (MR) imaging across different field …

Background & Aims The intestinal microbiome might affect the development and severity of
nonalcoholic fatty liver disease (NAFLD). We analyzed microbiomes of children with and …

Nonalcoholic fatty liver disease (NAFLD) is a frequent cause of chronic liver diseases,
ranging from simple steatosis to nonalcoholic steatohepatitis (NASH)-related liver cirrhosis …

Resveratrol is a natural compound that affects energy metabolism and mitochondrial
function and serves as a calorie restriction mimetic, at least in animal models of obesity …

Retrospective studies have shown that two‐dimensional magnetic resonance elastography
(2D‐MRE), a novel MR method for assessment of liver stiffness, correlates with advanced …

Hepatic steatosis is characterized by abnormal and excessive accumulation of lipids within
hepatocytes. It is an important feature of diffuse liver disease, and the histological hallmark …

The magnetic resonance imaging–estimated proton density fat fraction (MRI‐PDFF) is a
novel imaging‐based biomarker that allows fat map** of the entire liver, whereas the …